STOCK TITAN

Inogen (INGN) DEF 14A Filings

INGN NASDAQ

Here are the DEF 14A proxy statements from Inogen Inc (INGN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow INGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INGN filings page.

Rhea-AI Summary

Inogen, Inc. is asking stockholders to vote at its virtual 2026 Annual Meeting on June 5, 2026, with a record date of April 6, 2026 covering 27,324,616 shares of common stock.

Key proposals include electing two Class III directors, ratifying Deloitte & Touche as auditor, an advisory say‑on‑pay vote, approving an Amended and Restated 2023 Equity Incentive Plan, and amending the Charter to declassify the Board. The company highlights a strategic turnaround that returned it to positive Adjusted EBITDA in 2025, refreshed leadership with a new independent director and key executives, and a Board-approved share repurchase program. It also emphasizes active stockholder engagement, including a Cooperation Agreement with certain investors and a Board governance change to move from a classified to a declassified structure.